Trial intelligence / Profile preview

Formoterol Fumarate in Patients With COPD

NCT00215384Phase 2Completed

Sponsor
Dey
Primary completion
Apr 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Dey. Status: completed.

02

Drugs

formoterol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00215384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00215384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call